Peter Openshaw
Chair, Governance Committee @Academy of Medical Sciences
Signup · Get unlimited contacts
WORK HISTORY
Chair, Governance Committee @Academy of Medical Sciences
London, GB
Lead Governor on governance for the Academy
EDUCATION
Guy's Hospital
MB BS BSc, Medicine and Surgery
Guy's Hospital, University of London
Bachelor of Medicine, Bachelor of Surgery (MBBS), Medicine
Bootham School, York
A levels
Sidcot School, Somerset
O levels, O level subjects
SKILLS
ABOUT PETER OPENSHAW
Peter Openshaw CBE FMedSci FRCP is Professor of Experimental Medicine within the National Heart and Lung Institute of Imperial College London. A respiratory physician and mucosal immunologist, he works on how the immune response both protects against viral infection but also causes disease. He has published over 400 papers on vaccinology, the immunopathogenesis of pulmonary viral diseases and lung inflammation and has received prizes for his lifetime contribution to RSV research (Chanock Award, 2012), the EFIS Ehrlich/Metchnikoff Medal (2014) and the Per Brandtzaeg Distinguished Scientific Achievement Award in Mucosal Immunology (2024). He was the first clinical President of the British Society for Immunology (2013-18), former President of the International RSV Society (20••••25) and is a Council Member of the Academy of Medical Sciences (Chair of Governance Committee). He is a Trustee of the Science Media Centre, of the European Scientific Working group on Influenza (ESWI), of the International Society for Respiratory Viruses (ISRV) and Director of the HIC-Vac consortium (promoting human experimental challenge to accelerate vaccinology). He has served on scientific advisory boards for GSK, Sanofi, Seqirus, AstraZeneca, BioNet (Asia), Pfizer, Moderna and Shionogi.He advised the UK government on pandemics (SAGE, 2009-12; Chair/Vice-Chair of NERVTAG, 20••••22). He was made a Commander of the British Empire for services to Medicine and Immunology in 2022 and awarded the Imperial College Medal 2024 for his work as Consul, reforming the university’s Ethos, Values and Behaviours. In June 2025, he was appointed to Main Panel A of the UK’s Research Excellence Framework (REF2029), Chairing Subpanel 1 (Clinical Medicine).
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.